Outer membrane protein p6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines

Infection and Immunity

Volumn 73, Issue 5, 2005, Pages 2728-2735

  Berenson, Charles S ^a,b   Murphy, Timothy F ^a   Wrona, Catherine T ^a   Sethi, Sanjay ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; ENDOTOXIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN P2; OUTER MEMBRANE PROTEIN P6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BLOOD CELL; CELL MEMBRANE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DONOR; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MEASUREMENT; MONOCYTE; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PURIFICATION; PURIFICATION; SUPERNATANT; THEORETICAL STUDY; UPREGULATION;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CYTOKINES; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 17644402144     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.5.2728-2735.2005     Document Type: Article

References (44)

1. Abe, Y., T. F. Murphy, S. Sethi, H. S. Faden, J. Dmochowski, Y. Harabuchi, and Y. M. Thanavala. 2002. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165:967-971.
2. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736-739.
3. Badr, W. H., D. Loghmanee, R. J. Karalus, T. F. Murphy, and Y. Thanavala. 1999. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses. Vaccine 18:29-37.
4. Berenson, C. S., M. A. Gallery, J. M. Smigiera, and R. H. Rasp. 2002. The role of ceramide of human macrophage gangliosides in activation of human macrophages. J. Leukoc. Biol. 72:492-502.
5. Berenson, C. S., M. A. Patterson, M. A. Pattoli, and T. F. Murphy. 1996. A monoclonal antibody to human macrophage gangliosides inhibits macrophage migration. J. Leukoc. Biol. 59:371-379.
6. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736.
7. Campagnari, A. A., M. R. Gupta, K. C. Dudas, T. F. Murphy, and M. A. Apicella. 1987. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect. Immun. 55:882-887.
8. Cordero, E., J. Pachin, A. Rivero, J. A. Giron, J. Gomez-Mateos, M. D. Merino, M. Torres-Tortosa, M. Gonzalez-Serrano, L. Aliaga, A. Collado, J. Hernandez-Quero, A. Barrera, and E. Nuno. 2000. Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Clin. Infect. Dis. 30:461-465.
9. Craig, J. E., A. Cliffe, K. Garnett, and N. J. High. 2001. Survival of nontypeable Haemophilus influenzae in macrophages. FEMS Microbiol. Lett. 203:55-61.
10. Fisette, P. L., S. Ram, J. M. Andersen, W. Guo, and R. R. Ingalls. 2003. The lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kB activation in epithelial cells in a TLR2-dependent manner. J. Biol. Chem. 278:46252-46260.
11. Forsgren, J., A. Samuelson, A. Ahlin, J. Jonasson, B. Rynnel-Dagoo, and A. Lindberg. 1994. Haemophilus influenzae resides and multiplies intracellularly in human adenoidal tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect. Immun. 62:673-679.
12. Galdiero, M., M. D'Amico, F. Gorga, C. Di Filippo, M. D'Isanto, M. Vitiello, A. Longanella, and A. Tortora. 2001. Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain. Infect. Immun. 69:221-227.
13. Galdiero, M., M. Galdiero, E. Finamore, F. Rossano, M. Gambuzza, M. R. Catania, G. Teti, A. Midiri, and G. Mancuso. 2004. Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infect. Immun. 72:1204-1209.
14. Gomis, S. M., D. L. Godson, T. Beskorwayne, G. A. Wobeser, and A. A. Potter. 1997. Modulation of phagocytic function of bovine mononuclear phagocytes by Haemophilus somnus. Microb. Pathog. 22:13-21.
15. Gomis, S. M., D. L. Godson, G. A. Wobeser, and A. A. Potter. 1998. Intracellular survival of Haemophilus somnus in bovine blood monocytes and alveolar macrophages. Microb. Pathog. 25:227-235.
16. Green, B. A., B. J. Metcalf, T. Quinn-Dey, D. H. Kirklcy, S. A. Quataert, and R. A. Deich. 1990. A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypeable and type b H. influenzae. Infect. Immun. 58:3272-3278.
17. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Woolen, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 163:2382-2386.
18. Hitchcock, P. J., and D. C. Morrison. 1984. The protein component of bacterial endotoxins, p. 339-375. In E. T. Rietschel (ed.), Chemistry of endotoxins. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
19. Hoch, R. C., I. U. Schraufstatter, and C. G. Cochrane. 1996. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. J. Lab. Clin. Med. 128:134-145.
20. Jonsson, S., D. M. Musher, and E. C. Lawrence. 1987. Phagocytosis and killing of Haemophilus influenzae by alveolar macrophages: no differences between smokers and non-smokers. Eur. J. Respir. Dis. 70:309-315.
21. Karalus, R. J., and T. F. Murphy. 1999. Purification and characterization of the outer membrane protein P6, a vaccine antigen of nontypeable Haemophilus influenzae. FEMS Immunol. Med. Microbiol. 26:159-166.
22. Khair, O. A., R. J. Davies, and J. L. Devalia. 1996. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur. Respir. J. 9:1913-1922.
23. Lee, N. A., and J. J. Lee. 1999. The macroimportance of the pulmonary microenvironment. Am. J. Respir. Cell Mol. Biol. 21:298-302.
24. Moller, L. V. M., W. Timens, W. van der Bij, K. Kooi, B. de Wever, J. Dankert, and L. van Alphen. 1998. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am. J. Respir. Crit. Care Med. 157:950-956.
25. Morr, M., O. Takeuchi, S. Akira, M. M. Simon, and P. F. Muhlradt. 2002. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 32:3337-3347.
26. Murphy, T. F., and M. A. Apicella. 1987. Nontypeable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev. Infect. Dis. 9:1-15.
27. Murphy, T. F., and L. C. Bartos. 1988. Purification and analysis with monoclonal antibodies of P2, the major outer membrane protein of nontypeable Haemophilus influenzae. Infect. Immun. 56:1084-1089.
28. Murphy, T. F., and L. C. Bartos. 1988. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect. Immun. 56:2673-2679.
29. Murphy, T. F., K. C. Dudas, J. M. Mylotte, and M. A. Apicella. 1983. A subtyping system for nontypable Haemophilus influenzae based on outermembrane proteins. J. Infect. Dis. 147:838-846.
30. Noel, G. J., S. K. Hoiseth, and P. J. Edelson. 1992. Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. J. Infect. Dis. 166:178-182.
31. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471.
32. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
33. Sethi, S., K. Muscarella, N. Evans, K. L. Klingman, B. J. Grant, and T. F. Murphy. 2000. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 118:1557-1565.
34. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-kappa B by nontypeable Haemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98:8774-8779.
35. Taga, K., H. Mostowski, and G. Tosata. 1993. Human interleukin-10 can directly inhibit T cell growth. Blood 81:2964-2971.
36. Takeuchi, O., A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, M. Morr, P. F. Muhlradt, and S. Akira. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164:554-557.
37. Tanino, M., T. Betsuyaku, K. Takeyabu, Y. Tanino, E. Yamaguchi, K. Miyamoto, and M. Nishimura. 2002. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 57:405-411.
38. Trinchieri, G. 1998. Proinflammatory and immunoregulatory functions of interleukin-12. 1998. Int. Rev. Immunol. 16:365-396.
39. Wang, B., P. P. Cleary, H. Xu, and J. D. Li. 2003. Up-regulation of interleukin-8 by novel small cytoplasmic molecules of nontypeable Haemophilus influenzas via p38 and extracellular signal-regulated kinase pathways. Infect. Immun. 71:5523-5530.
40. Wang, X., C. Moser, J. P. Louboutin, E. S. Lysenko, D. J. Weiner, J. N. Weiser, and J. M. Wilson. 2002. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168:810-815.
41. Westphal, O., and K. Jann. 1954. p. 83-91. Extraction with phenol-water and further applications of the procedure. In Methods in carbohydrate chemistry. Academic Press, Inc., New York, N.Y.
42. Williams, A. E., D. J. Maskell, and E. R. Moxon. 1991. Relationship between intracellular survival in macrophages and virulence of Haemophilus influenzae type b. J. Infect. Dis. 163:1366-1369.
43. Yang, Y. P., R. S. Munson, S. Grass, P. Chong, R. E. Harkness, L. Gisonni, O. James, Y. Kwok, and M. H. Klein. 1997. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6. Vaccine 15:976-987.
44. Yi, K., and T. F. Murphy. 1997. Importance of an immunodominant surface-exposed loop on outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect. Immun. 65:150-155.